-

Boston Children’s Hospital and OpenEvidence Collaborate to Advance AI-Powered Analysis of Clinical Practice Patterns

MIAMI & BOSTON--(BUSINESS WIRE)--Boston Children's Hospital, one of the nation's top pediatric hospitals, and OpenEvidence, the leading AI-powered clinical decision support platform, today announced a multi-year collaboration to examine how clinicians' real-world use of AI tools at the point of care relates to practice patterns and delivery of care.

"This initiative brings together Boston Children's deep clinical expertise and OpenEvidence's clinical evidence platform."

Share

OpenEvidence has seen broad adoption in clinical settings, yet little is known about how that adoption relates to clinical practice patterns at a population level. By bringing together one of the leading pediatric academic medical centers at the forefront of clinical innovation with the most widely used medical AI platform, the collaboration is positioned to evaluate the relationship between OpenEvidence and real-world clinical practice at a scale and resolution not previously possible. To ensure patient privacy, the teams will focus on analyzing only aggregated, provider-level data; no patient-level data will be accessed or used.

"This initiative brings together Boston Children's deep clinical expertise and OpenEvidence's clinical evidence platform to better understand care delivery and help children thrive, while preserving patient privacy," said John Brownstein, PhD, Chief Innovation Officer at Boston Children's Hospital. "OpenEvidence has quickly become a trusted, everyday resource at the point of care, supporting millions of patient visits across the U.S. By analyzing anonymous patterns in how clinicians ask and answer questions during these encounters, we can surface insights into health trends that would otherwise remain hidden—and, in collaboration with OpenEvidence, continue helping clinicians deliver better care."

The collaboration includes an integration that enables Boston Children's clinicians to access OpenEvidence directly within the electronic health record, reflecting how central the tool has become to clinical workflows at Boston Children's. "As a pediatrician who trained and practiced at Boston Children's before joining OpenEvidence, I have watched the tool go from nonexistent to indispensable among my colleagues in a remarkably short period of time," said Mondira Ray, MD, MBI, Senior Vice President of Clinical Informatics at OpenEvidence. "OpenEvidence has become part of how clinicians practice. A change this visible carries implications we are eager to examine."

Boston Children’s Hospital is ranked among the best children’s hospitals in the nation by U.S. News & World Report and is a pediatric teaching affiliate of Harvard Medical School. Home to the world’s largest research enterprise based at a pediatric medical center, Boston Children’s has led the way in life-changing pediatric innovation since its founding in 1869. Today, 3,000 researchers and scientific staff, including 15 members of the National Academy of Sciences, 37 members of the National Academy of Medicine and 13 Howard Hughes Medical Investigators across ~1M square feet of lab space comprise the research community. From bench to bedside, scientists work on preventing, treating, and curing diseases that impact both children and adults, no matter how rare or complex the condition. Founded as a 20-bed hospital for children, Boston Children’s is now a 491-bed comprehensive center for pediatric and adolescent health care.

With nine satellite locations and the Martha Elliot Health Center, Boston Children’s also provides 24/7 pediatric care at five hospitals including Beverly Hospital, Winchester Hospital, St. Luke’s Hospital, South Shore Hospital and Cape Cod Hospital.

Boston Children’s also includes: Affiliation with Franciscan Children’s Hospital, including 112 beds and 700+ employees; Boston Children’s Primary Care Alliance, a robust network of 33 pediatric practices serving patients and families throughout Massachusetts; The Pediatric Physicians’ Organization at Boston Children’s Hospital (PPOC) with more than 400 physicians, nurse practitioners, and physician assistants devoted exclusively to pediatric primary care, in close collaboration with subspecialists at Boston Children’s in more than 90 locations throughout Massachusetts; Boston Children’s Health Physicians (BCHP) which is the largest pediatric multispecialty group in New York's Metropolitan Area, the Hudson Valley, and Connecticut, including nearly 300 clinicians in more than 60 locations.

For more, visit our Answers blog and follow us on Facebook, YouTube, and LinkedIn.

About OpenEvidence

OpenEvidence is the fastest-growing and most widely-used clinical decision support platform in the United States, and the most widely used medical search engine among U.S. clinicians. OpenEvidence is trusted by hundreds of thousands of verified healthcare professionals to make high-stakes clinical decisions at the point of care that are sourced, cited, and grounded in peer-reviewed medical literature. Founded with the mission to organize and expand global medical knowledge, OpenEvidence is actively used daily, on average, by the majority of physicians in the United States. Learn more at openevidence.com

Contacts

OpenEvidence

Details
Headquarters: Miami, FL
CEO: Daniel Nadler
Employees: na
Organization: PRI

Release Versions

Contacts

Social Media Profiles
More News From OpenEvidence

American Academy of Pediatrics and OpenEvidence Announce Collaboration to Improve Pediatric Care

MIAMI & ITASCA, Ill.--(BUSINESS WIRE)--Clinicians caring for children to benefit from evidence-based recommendations from AAP being incorporated into responses on the OpenEvidence platform....

OpenEvidence and NewYork-Presbyterian, Columbia University and Weill Cornell Medicine Expand Clinical AI Tools Across New York City and Westchester

MIAMI & NEW YORK--(BUSINESS WIRE)--OpenEvidence, a medical AI and clinical decision support tool for U.S. clinicians, today announced a collaboration with NewYork-Presbyterian and its affiliated medical schools, Columbia University Vagelos College of Physicians and Surgeons and Weill Cornell Medicine, to deploy OpenEvidence across all hospitals and care sites throughout the Greater New York region. This enterprise-scale collaboration will place trusted, evidence-based clinical AI in the hands o...

OpenEvidence, Anticoagulation Forum Partner to Expand Access to AI-Enabled Guidance in Antithrombotic Care

MIAMI & BOSTON--(BUSINESS WIRE)--OpenEvidence and the Anticoagulation Forum (AC Forum) today announced a strategic partnership to provide antithrombotic guidance and tools that support decision-making in clinical practice. By combining the AC Forum’s leadership in education and multidisciplinary clinical guidance with OpenEvidence’s advanced artificial intelligence platform, clinicians will gain access to timely and practical evidence in antithrombotic therapy. “Clinicians are increasingly turn...
Back to Newsroom